Acadia Pharmaceuticals
ACAD on XNAS, Acadia Pharmaceuticals Inc.
Measures activity, not value. Not investment advice.
Latest month (Jan 2018)
-$867K
Not enough history to drawLast 12 months
-$867K
vs the 12 months before
Sharp changes
0
federal obligations jump, first federal award, first award from a new federal agency
What usually follows Federal contracts growth was not followed by a clear share-price difference over the next 6 months. No relationship found How we measured it
USAspending.gov obligations by date. Dashed: 3-year median.
See the numbers
| Month of Jan 2018: -$867K |
What the numbers say
- Federal obligations: -$867K in January 2018.
Sharp changes
0 in all loaded history, strongest first
No sharp change of this kind in all loaded history.
The records
Newest first, by the day each became public
No records in all loaded history with these filters.